ANDAORALTABLET, ORALLY DISINTEGRATING
Approved
Oct 2015
Lifecycle
Post-LOE
Competitive Pressure
30/100
Clinical Trials
2
Data completeness
4/8 — Partial
ZOLMITRIPTAN (zolmitriptan) by Ichnos Glenmark Innovation is serotonin 1b receptor agonists [moa]. Approved for serotonin-1b and serotonin-1d receptor agonist [epc]. First approved in 2015.
Drug data last refreshed 20h ago
Mechanism of Action
Serotonin 1b Receptor Agonists
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (2)
Determine Central 5-HT1B Receptor Occupancy of ZOMIG® Rapimelt (Zolmitriptan) in Healthy Male Volunteers
Started May 2010
10 enrolled
Migraine
Efficacy and Tolerability of Zolmitriptan Nasal Spray
Started Sep 2002
2,114 enrolled
Migraine
Company
Worked on ZOLMITRIPTAN at Ichnos Glenmark Innovation? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.